Evidence map›Paper›PMID 37969851›Full record

ReviewHCA healthcare journal of medicine2023

Atrial Fibrillation: Rate Versus Rhythm Control.

Carlos E Vargas, Mina Bhatnagar, Haris Ahmed, Michael G Flynn, Thomas Alexander

Abstract readReview
In one paragraph

Review in HCA healthcare journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlos E VargasCorpus Christi Medical Center, Corpus Christi, TX.
Mina BhatnagarMountainView Hospital, Las Vegas, NV.
Haris AhmedHCA Houston Healthcare Kingwood, Kingwood, TX.
Michael G FlynnHCA Healthcare Graduate Medical Education, Brentwood, TN.
Thomas AlexanderCorpus Christi Medical Center, Corpus Christi, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Description Atrial fibrillation (AF) remains the most common arrhythmia worldwide and is expected to affect approximately 12 million individuals in the United States alone by 2030. Thromboembolic events remain a feared complication of AF and should be treated and risk-stratified utilizing the CHA

Indexed as

anti-arrhythmic drugsatrial fibrillation (AF)atrial fibrosiscatheter ablationelectrical cardioversionquality of life (QoL)rate controlrhythm control

Identifiers

PMID37969851
PMCPMC10635694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.